Biotech takeover target Abivax sinks over 30% as cancer cases cloud trial data for bowel disease drug
A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.
Biotech takeover target Abivax sinks over 30% as cancer cases cloud trial data for bowel disease drug basliginda one cikan gelisme: A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.